Tasigna advantage in treatment of newly diagnosed chronic myeloid leukemia: results of «Novartis research»

QR Code

Tasigna advantage in treatment of newly diagnosed chronic myeloid leukemia: results of «Novartis research»

.

Saved in:

Bibliographic Details
Main Author:	article Editorial
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/787
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment
by: Oudai Alkabbani, et al.
Published: (2025-07-01)

COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS
by: R. I. Yagudina, et al.
Published: (2015-03-01)

COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia
by: Tracy Murphy, et al.
Published: (2025-07-01)

Association of Pretreatment Serum Indirect Bilirubin Levels With Prognostic and Therapeutic Value in Patients With Newly Diagnosed Acute Myeloid Leukemia
by: Chunfang Kong, et al.
Published: (2025-02-01)

Results of various somatic mutations detection in patients with chronic myeloid leukemia
by: E. A. Kuzmina, et al.
Published: (2024-12-01)

Targeted therapy of newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. A single-center ambispective cohort study
by: N. K. Pastukhov, et al.
Published: (2025-03-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

Bosutinib for Successful Treatment‐Free Remission in Chronic Myeloid Leukemia
by: Yuki Fujioka, et al.
Published: (2025-05-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials.
by: Qiang Gong, et al.
Published: (2015-01-01)

Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01)

Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition
by: V. S. Nemirovchenko, et al.
Published: (2020-07-01)

Treatment of acute myeloid leukemia in children
by: A. V. Popa, et al.
Published: (2022-11-01)

Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia
by: Yiming Cai, et al.
Published: (2025-07-01)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

TELOMERES AND TELOMERASE ACTIVITY IN CHRONIC MYELOID LEUKEMIA (REVIEW)
by: A. S. Lyamkina, et al.
Published: (2019-03-01)

PECULIARITIES OF CHRONIC MYELOID LEUKEMIA INCIDENCE IN THE ALTAi krai
by: O. V. Efremova, et al.
Published: (2019-05-01)

Advancing quality of life research in chronic myeloid leukemia: where do we stand?
by: Jeffrey H. Lipton
Published: (2025-07-01)

Transformation of Chronic Myeloid Leukemia to Acute Undifferentiated Leukemia: Case Report and Literature Review
by: Oussama Grari, et al.
Published: (2025-04-01)

Chronic myeloid leukemia — before and after imatinib (part II)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

The Value of Molecular Response in Chronic Myeloid Leukemia: The Present and the Future
by: Falchi, Lorenzo, et al.
Published: (2012)

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
by: Takahashi, Naoto, et al.
Published: (2012)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

CHRONIC MYELOID LEUKEMIA - CLINICAL AND IMMUNOLOGICAL PECULIARITIES IN ADULT PATIENTS
by: O. V. Smirnova
Published: (2012-05-01)

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
by: Chen J, et al.
Published: (2025-07-01)

COVID-19 PANDEMIC AND CHRONIC MYELOID LEUKEMIA: A REVIEW
by: Hafiza Sidra Bashir, et al.
Published: (2022-10-01)

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia
by: N. A. Avxentyev, et al.
Published: (2018-08-01)

Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
by: E. Agostani, et al.
Published: (2025-02-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Establishment and Application of Warning Scoring System for Bleeding Severity in Patients with Newly Diagnosed Acute Promyelocytic Leukemia
by: Xueqin Li MM, et al.
Published: (2025-07-01)